Polygenic risk modeling for prediction of epithelial ovarian cancer risk (vol 30, pg 349, 2021)

被引：1

作者：

Dareng, Eileen O.

Tyrer, Jonathan P.

Barnes, Daniel R.

Jones, Michelle R.

Yang, Xin

Aben, Katja K. H.

Adank, Muriel A.

Agata, Simona

Andrulis, Irene L.

Anton-Culver, Hoda

Antonenkova, Natalia N.

Aravantinos, Gerasimos

Arun, Banu K.

Augustinsson, Annelie

Balmana, Judith

Bandera, Elisa V.

Barkardottir, Rosa B.

Barrowdale, Daniel

Beckmann, Matthias W.

Beeghly-Fadiel, Alicia

Benitez, Javier

Bermisheva, Marina

Bernardini, Marcus Q.

Bjorge, Line

Black, Amanda

Bogdanova, Natalia V.

Bonanni, Bernardo

Borg, Ake

Brenton, James D.

Budzilowska, Agnieszka

Butzow, Ralf

Buys, Saundra S.

Cai, Hui

Caligo, Maria A.

Campbell, Ian

Cannioto, Rikki

Cassingham, Hayley

Chang-Claude, Jenny

Chanock, Stephen J.

Chen, Kexin

Chiew, Yoke-Eng

Chung, Wendy K.

Claes, Kathleen B. M.

Colonna, Sarah

Cook, Linda S.

Couch, Fergus J.

Daly, Mary B.

Dao, Fanny

Davies, Eleanor

de la Hoya, Miguel

机构：

[1] University of Cambridge,The Netherlands Cancer Institute—Antoni van Leeuwenhoek hospital

[2] Centre for Cancer Genetic Epidemiology,Lunenfeld

[3] Department of Public Health and Primary Care,Tanenbaum Research Institute of Mount Sinai Hospital

[4] University of Cambridge,Rutgers Cancer Institute of New Jersey

[5] Centre for Cancer Genetic Epidemiology,National Cancer Institute

[6] Department of Oncology,Hannover Medical School

[7] Center for Bioinformatics and Functional Genomics,Hannover Medical School

[8] Cedars-Sinai Medical Center,IEO, European Institute of Oncology IRCCS

[9] Radboud University Medical Center,Cancer Research UK Cambridge Institute

[10] Radboud Institute for Health Sciences,Roswell Park Cancer Institute, Cancer Pathology & Prevention

[11] Netherlands Comprehensive Cancer Organisation,Division of Human Genetics

[12] Family Cancer Clinic,German Cancer Research Center (DKFZ)

[13] Veneto Institute of Oncology IOV—IRCCS,National Cancer Institute, National Institutes of Health, Department of Health and Human Services

[14] Immunology and Molecular Oncology Unit,CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos)

[15] Fred A. Litwin Center for Cancer Genetics,Vall dHebron Institute of Oncology (VHIO)

[16] University of Toronto,Brigham and Women’s Hospital and Harvard Medical School

[17] Department of Molecular Genetics,Magee

[18] University of California Irvine,Womens Hospital

[19] Department of Epidemiology,Aichi Cancer Center Research Institute

[20] Genetic Epidemiology Research Institute,Samuel Lunenfeld Research Institute

[21] N.N. Alexandrov Research Institute of Oncology and Medical Radiology,Roswell Park Cancer Institute, NRG Oncology

[22] ‘Agii Anargiri’ Cancer Hospital,National Cancer Centre

[23] University of Texas MD Anderson Cancer Center,Institute of Biochemistry and Experimental Oncology, First Faculty od Medicine

[24] Department of Breast Medical Oncology,undefined

[25] Lund University,undefined

[26] Department of Cancer Epidemiology,undefined

[27] Clinical Sciences,undefined

[28] Vall d’Hebron Institute of Oncology,undefined

[29] Hereditary cancer Genetics Group,undefined

[30] University Hospital of Vall d’Hebron,undefined

[31] Department of Medical Oncology,undefined

[32] Cancer Prevention and Control Program,undefined

[33] Landspitali University Hospital,undefined

[34] Department of Pathology,undefined

[35] University of Iceland,undefined

[36] BMC (Biomedical Centre),undefined

[37] Faculty of Medicine,undefined

[38] University Hospital Erlangen,undefined

[39] Friedrich-Alexander-University Erlangen-Nuremberg,undefined

[40] Department of Gynecology and Obstetrics,undefined

[41] Comprehensive Cancer Center ER-EMN,undefined

[42] Vanderbilt University School of Medicine,undefined

[43] Division of Epidemiology,undefined

[44] Department of Medicine,undefined

[45] Vanderbilt Epidemiology Center,undefined

[46] Vanderbilt-Ingram Cancer Center,undefined

[47] Biomedical Network on Rare Diseases (CIBERER),undefined

[48] Spanish National Cancer Research Centre (CNIO),undefined

[49] Human Cancer Genetics Programme,undefined

[50] Ufa Federal Research Centre of the Russian Academy of Sciences,undefined

来源：

EUROPEAN JOURNAL OF HUMAN GENETICS | 2022年 / 30卷 / 05期

关键词：

D O I：

10.1038/s41431-022-01085-y

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：630 / 631

页数：2

共 50 条

[31] Estimating the Risk of Ovarian Cancer (vol 80, pg 632, 2009)
Ebell, M. H.
AMERICAN FAMILY PHYSICIAN, 2009, 80 (10) : 1058 - 1058
[32] A polygenic methylation prediction model associated with response to chemotherapy in epithelial ovarian cancer
Zhao, Lanbo
Ma, Sijia
Wang, Linconghua
Wang, Yiran
Feng, Xue
Liang, Dongxin
Han, Lu
Li, Min
Li, Qiling
MOLECULAR THERAPY ONCOLYTICS, 2021, 20 : 545 - 555
[33] Ranitidine Use and Risk of Upper Gastrointestinal Cancers (vol 30, pg 2302, 2021)
Adami, Hans-Olov
Andersen, Ina Trolle
Heide-Jorgensen, Uffe
Chang, Ellen T.
Norgaard, Mette
Sorensen, Henrik Toft
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (03) : 692 - 692
[34] CHEMICALS AND CANCER - ESTIMATING THE RISK (VOL 30, PG 661, 1994)
WATSON, WP
BLEASDALE, C
GOLDING, BT
CHEMISTRY IN BRITAIN, 1994, 30 (10) : 835 - 835
[35] Breast and Ovarian Cancer Risk and Risk Reduction in Jewish BRCA1/2 Mutation Carriers (vol 30, pg 1321, 2012)
Finkelman
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (18) : 2290 - 2290
[36] Utilizing polygenic risk score for breast cancer risk prediction in a Taiwanese population
Lin, Yi-Hsuan
Hung, Chih-Chiang
Lin, Guan-Cheng
Tsai, I. -Chen
Lum, Chih Yean
Hsiao, Tzu-Hung
CANCER EPIDEMIOLOGY, 2025, 94
[37] BREAST CANCER RISK PREDICTION USING A COMBINED CLINICAL RISK CALCULATOR AND POLYGENIC RISK SCORE
Shieh, Yiwey
Hu, Donglei
Ma, Lin
Gard, Charlotte C.
Leung, Jessica
Tice, Jeffrey A.
Vachon, Celine M.
Cummings, Steven R.
Kerlikowske, Karla
Ziv, Elad
JOURNAL OF GENERAL INTERNAL MEDICINE, 2016, 31 : S141 - S141
[38] Gastric Cancer Risk Prediction Using an Epidemiological Risk Assessment Model and Polygenic Risk Score
Park, Boyoung
Yang, Sarah
Lee, Jeonghee
Choi, Il Ju
Kim, Young-Il
Kim, Jeongseon
CANCERS, 2021, 13 (04) : 1 - 13
[39] Polygenic Risk Scores have high diagnostic capacity in ankylosing spondylitis (vol 80, pg 1168, 2021)
Li, Zhixiu
Wu, Xin
Leo, Paul J.
De Guzman, Erika
Akkoc, Nurullah
Breban, Maxime
Macfarlane, Gary J.
Mahmoudi, Mahdi
Marzo-Ortega, Helena
Anderson, Lisa K.
Wheeler, Lawrie
Chou, Chung-Tei
Harrison, Andrew A.
Stebbings, Simon
Jones, Gareth T.
Bang, So-Young
Wang, Geng
Jamshidi, Ahmadreza
Farhadi, Elham
Song, Jing
Lin, Li
Li, Mengmeng
Wei, James Cheng-Chung
Martin, Nicholas G.
Wright, Margaret J.
Lee, MinJae
Wang, Yuqin
Zhan, Jian
Zhang, Jin-San
Wang, Xiaobing
Jin, Zi-Bing
Weisman, Michael H.
Gensler, Lianne S.
Ward, Michael M.
Rahbar, Mohammad Hossein
Diekman, Laura
Kim, Tae-Hwan
Reveille, John D.
Wordsworth, Bryan Paul
Xu, Huji
Brown, Matthew A.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (11) : E187 - E187
[40] Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk
Thomas, Minta
Sakoda, Lori C.
Hoffmeister, Michael
Rosenthal, Elisabeth A.
Lee, Jeffrey K.
van Duijnhoven, Franzel J. B.
Platz, Elizabeth A.
Wu, Anna H.
Dampier, Christopher H.
de la Chapelle, Albert
Wolk, Alicja
Joshi, Amit D.
Burnett-Hartman, Andrea
Gsur, Andrea
Lindblom, Annika
Castells, Antoni
Win, Aung Ko
Namjou, Bahram
Van Guelpen, Bethany
Tangen, Catherine M.
He, Qianchuan
Li, Christopher, I
Schafmayer, Clemens
Joshu, Corinne E.
Ulrich, Cornelia M.
Bishop, D. Timothy
Buchanan, Daniel D.
Schaid, Daniel
Drew, David A.
Muller, David C.
Duggan, David
Crosslin, David R.
Albanes, Demetrius
Giovannucci, Edward L.
Larson, Eric
Qu, Flora
Mentch, Frank
Giles, Graham G.
Hakonarson, Hakon
Hampel, Heather
Stanaway, Ian B.
Figueiredo, Jane C.
Huyghe, Jeroen R.
Minnier, Jessica
Chang-Claude, Jenny
Hampe, Jochen
Harley, John B.
Visvanathan, Kala
Curtis, Keith R.
Offit, Kenneth
AMERICAN JOURNAL OF HUMAN GENETICS, 2020, 107 (03) : 432 - 444

← 1 2 3 4 5 →